Inventor · disambiguated record
Jiehua Zhou
Also filed as: ZHOU JIEHUA
12 granted patents·60 citations·filing 2008–2021
89Inventor score
Top patents by PatentIndex Score
12 records- 0195US9605266B2Cell-specific internalizing RNA aptamers against human CCR5 and uses thereforeHOPE CITY·Filed 2015·Granted Mar 28, 2017·24 cites·12 claims
- 0293US8030290B2Cell-type specific aptamer-siRNA delivery system for HIV-1 TherapyHOPE CITY·Filed 2008·Granted Oct 4, 2011·13 cites·5 claims
- 0392US8222226B2Cell-type specific aptamer-siRNA delivery system for HIV-1 therapyROSSI JOHN J·Filed 2011·Granted Jul 17, 2012·9 cites·18 claims
- 0491US10167474B2Cell-specific internalizing RNA aptamers against human CCR5 and uses thereforeHOPE CITY·Filed 2017·Granted Jan 1, 2019·6 cites·18 claims
- 0589US9506064B2Cell-type specific aptamer-siRNA delivery system for HIV-1 therapyHOPE CITY·Filed 2015·Granted Nov 29, 2016·3 cites·19 claims
- 0685US9163241B2Cell-type specific aptamer-siRNA delivery system for HIV-1 therapyROSSI JOHN J·Filed 2011·Granted Oct 20, 2015·3 cites·11 claims
- 0781US10041071B2Cell-type specific aptamer-siRNA delivery system for HIV-1 therapyHOPE CITY·Filed 2016·Granted Aug 7, 2018·1 cites·26 claims
- 0873US9006416B2RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their useHOPE CITY·Filed 2012·Granted Apr 14, 2015·1 cites·29 claims
- 0972US12194056B2CCR7 aptamers and uses thereofHOPE CITY·Filed 2021·Granted Jan 14, 2025·0 cites·15 claims
- 1067US11007211B2CCR7 aptamers and uses thereofHOPE CITY·Filed 2019·Granted May 18, 2021·0 cites·15 claims
- 1159US9695425B2RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their useHOPE CITY·Filed 2016·Granted Jul 4, 2017·0 cites·17 claims
- 1258US9353374B2RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their useHOPE CITY·Filed 2015·Granted May 31, 2016·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Jiehua Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →